Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: AstraZeneca
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
NCT02558894
Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.